Literature DB >> 19651439

Genetic susceptibility to childhood acute lymphoblastic leukemia shows protection in Malay boys: results from the Malaysia-Singapore ALL Study Group.

Allen Eng-Juh Yeoh1, Yi Lu, Jason Yong-Sheng Chan, Yiong Huak Chan, Hany Ariffin, Shirley Kow-Yin Kham, Thuan Chong Quah.   

Abstract

To study genetic epidemiology of childhood acute lymphoblastic leukemia (ALL) in the Chinese and Malays, we investigated 10 polymorphisms encoding carcinogen- or folate-metabolism and transport. Sex-adjusted analysis showed NQO1 609CT significantly protects against ALL, whilst MTHFR 677CT confers marginal protection. Interestingly, we observed that NQO1 609CT and MTHFR 1298 C-allele have greater genetic impact in boys than in girls. The combination of SLC19A1 80GA heterozygosity and 3'-TYMS -6bp/-6bp homozygous deletion is associated with reduced ALL risk in Malay boys. Our study has suggested the importance of gender and race in modulating ALL susceptibility via the folate metabolic pathway. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19651439     DOI: 10.1016/j.leukres.2009.07.003

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  19 in total

1.  ABCB1 polymorphisms correlate with susceptibility to adult acute leukemia and response to high-dose methotrexate.

Authors:  Chuan-Xiang Ma; Yong-Hong Sun; Hai-Ying Wang
Journal:  Tumour Biol       Date:  2015-04-29

2.  Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole-genome sequences.

Authors:  A Sivadas; M Z Salleh; L K Teh; V Scaria
Journal:  Pharmacogenomics J       Date:  2016-05-31       Impact factor: 3.550

3.  Gene polymorphisms in the folate metabolic pathway and risk of pediatric acute lymphoblastic leukemia: a case-control study in a Chinese population.

Authors:  Hui Lv; Shao-Yan Hu; Zhi-Zuo Du; Zong Zhai; Lan Cao; Yi-Na Sun; Jun Lu; Jie Li; Hai-Long He; Yi-Huan Chai; Yi Wang
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

4.  Genetic variants in the folate pathway and risk of childhood acute lymphoblastic leukemia.

Authors:  Catherine Metayer; Ghislaine Scélo; Anand P Chokkalingam; Lisa F Barcellos; Melinda C Aldrich; Jeffrey S Chang; Neela Guha; Kevin Y Urayama; Helen M Hansen; Gladys Block; Vincent Kiley; John K Wiencke; Joseph L Wiemels; Patricia A Buffler
Journal:  Cancer Causes Control       Date:  2011-07-12       Impact factor: 2.506

Review 5.  Current evidence for an inherited genetic basis of childhood acute lymphoblastic leukemia.

Authors:  Kevin Y Urayama; Anand P Chokkalingam; Atsushi Manabe; Shuki Mizutani
Journal:  Int J Hematol       Date:  2012-12-13       Impact factor: 2.490

Review 6.  Association between NQO1 C609T polymorphism and acute lymphoblastic leukemia risk: evidence from an updated meta-analysis based on 17 case-control studies.

Authors:  Cuiping Li; Yang Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-02       Impact factor: 4.553

7.  Lack of Impact of the A1298C MTHFR on the Risk of Childhood Acute Lymphoblastic Leukemia: Evidence from a Meta-analysis.

Authors:  Rim Frikha
Journal:  Indian J Hematol Blood Transfus       Date:  2021-05-26       Impact factor: 0.900

Review 8.  Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.

Authors:  Carlos Rodriguez-Galindo; Paola Friedrich; Patricia Alcasabas; Federico Antillon; Shripad Banavali; Luis Castillo; Trijn Israels; Sima Jeha; Mhammed Harif; Michael J Sullivan; Thuan Chong Quah; Catherine Patte; Ching-Hon Pui; Ronald Barr; Thomas Gross
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

9.  MTHFR gene polymorphism in acute lymphoblastic leukemia among North Indian children: a case-control study and meta-analysis updated from 2011.

Authors:  Nirmalya Roy Moulik; Farah Parveen; Archana Kumar; Shally Awasthi; Suraksha Agrawal
Journal:  J Hum Genet       Date:  2014-06-12       Impact factor: 3.172

10.  The prevalence and clinical relevance of 2R/2R TYMS genotype in patients with gastrointestinal malignancies treated with fluoropyrimidine-based chemotherapy regimens.

Authors:  Moh'd Khushman; Girijesh Kumar Patel; Anu Singh Maharjan; Gwendolyn A McMillin; Cindy Nelson; Peter Hosein; Ajay P Singh
Journal:  Pharmacogenomics J       Date:  2021-02-19       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.